Summary : Novo Nordisk said it had invested 15 years of continuous research to make the oral formulation of semaglutide into a…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Category:
Launch
-
-
AgrochemicalsGlobal MarketIndiaLaunch
Cadila Pharma expands Oncology Portfolio with Launch of Tarzed
by adminby adminSynopsis : TARZED is considered safe and more efficacious compared to conventional treatment medicines for breast cancer. Cadila Pharmaceuticals Limited on Wednesday…
-
AgrochemicalsIndiaLaunch
Torrent Pharma to launch Molnupiravir under the Brand Name Molnutor in India
by adminby adminSynopsis: Torrent Pharma announced that it is introducing MSD (a trade name of Merck & Co., Inc, Kenilworth, New Jersey, USA) and…
-
Synopsis : – Slalom Launch Center to help Japanese organizations accelerate cloud transformation and modernize their technology services Amazon Web Services…
-
AgrochemicalsIndiaLaunch
BDR Pharma launches India’s First Generic Pazopanib to Treat Various Cancer .
by adminby adminSynopsis : Cabozantinib is used for the treatment of metastatic medullary thyroid cancer, advanced renal cell carcinoma and hepatocellular carcinoma, BDR Pharma…
-
AgrochemicalsGlobal MarketLaunch
BioRestorative Therapies Announces CRO Agreement with PRC Clinical for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
by adminby adminSummary – BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based therapies, today announced…
-
LaunchPharma Science & Research
MedMira Inc. Announces to Launch VYRA™ CoV2Flu Rapid Antigen Rapid Test
by adminby adminSummary – Launch of VYRA™ CoV2Flu Rapid Antigen Rapid Test (VYRA™ CoV2Flu). Based on MedMira’s proprietary technology, this 3-in-1 test is developed…
-
Cipla healthcare has launched Naselin antiviral nasal spray with Povidone Iodine that can offer the first line of defence against the COVID-causing…
-
Global MarketLaunch
Glenmark Pharmaceutical Launches First New Combination Drug for Type-2 Diabetes.
by adminby adminGlenmark Pharmaceuticals on Tuesday said it has launched a fixed-dose combination drug for the treatment of Type 2 diabetes in the country.…
-
Launch
Approaching footsteps by Aptar Pharma and i2c Pharmaceutical Services toward new partnership for co-development and promoting Respitab
by adminby adminSynopsis- Aptar Pharma and i2c Pharmaceutical Services joins hand for co-develop and promote i2c’s pressurized metered dose inhaler (pMDI) technology, Respitab.…